Daijiro Tomii (@daijirotomii) 's Twitter Profile
Daijiro Tomii

@daijirotomii

Interventional Cardiologist, Department of Cardiology Swiss Cardiovascular Center Inselspital, Bern University Hospital

ID: 1396028728656818177

calendar_today22-05-2021 09:02:55

142 Tweet

105 Followers

112 Following

Tsuyoshi Kaneko (@tsuyoshikaneko1) 's Twitter Profile Photo

Thanks for TCTMD and Yael L. Maxwell for interviewing. Both #TAVR and #SAVR is underutilized in zip codes with high area deprivation index. Important question for disease and therapy awareness. Socioeconomics Mire Access to All AVR Options for Aortic Stenosis tctmd.com/news/socioecon…

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

"Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial". An Editorial by Stephan Windecker and Daijiro Tomii ow.ly/1NWp50QuPM0

"Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial". An Editorial by Stephan Windecker and Daijiro Tomii 
ow.ly/1NWp50QuPM0
Thomas Pilgrim (@thompilgrim) 's Twitter Profile Photo

More than one in three climbers experienced cardiac arrhythmias during the ascent from base camp to the summit of Mount Everest. Find out more about the SUMMIT study JAMA Cardiology jamanetwork.com/journals/jamac…? Everest Today Stephanie Geiger Amy Woodyatt @alan_arnette Angela Benavides

Thomas Pilgrim (@thompilgrim) 's Twitter Profile Photo

In the SUMMIT study, we found a substantial incidence of cardiac arrhythmias among climbers on Mount Everest. Next, we will dive deeper into the pathomechanisms and try to identify individuals at increased risk of serious adverse events. jamanetwork.com/journals/jamac…?

TCTMD (@tctmd) 's Twitter Profile Photo

Thomas Pilgrim (Thomas Pilgrim) shares his #QuickTake on the risk of cardiac arrhythmia among men climbing Mount Everest, as seen in the SUMMIT study. Check out the full video here: tctmd.com/videos/tctmds-…

Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

TAVR in Low-Risk Patients with Bicuspid Aortic Stenosis. Is it promising? Nothing to worry about? Why do we need a dedicated randomized control trial comparing TAVR and SAVR? See our recent work in #JINT. |jacc.org/doi/10.1016/j.…

Thomas Pilgrim (@thompilgrim) 's Twitter Profile Photo

VARC-3 periprocedural myocardial injury was associated with a 2-fold increased risk of CV death at 1 year after TAVR. The favorable association of RAS inhibitor prescription was consistent in patients with and without periprocedural myocardial injury. authors.elsevier.com/sd/article/S27…

VARC-3 periprocedural myocardial injury was associated with a 2-fold increased risk of CV death at 1 year after TAVR. The favorable association of RAS inhibitor prescription was consistent in patients with and without periprocedural myocardial injury. authors.elsevier.com/sd/article/S27…
Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

TAVIの術前CTと血管合併症に関する論文です。 手技のexpertise が重要視されがちなinterventionの世界ですが、事前の解剖学的評価も包括的にしましょうね、という結果でした。

Thomas Pilgrim (@thompilgrim) 's Twitter Profile Photo

The inflammatory pathway offers a potential therapeutic target in patients undergoing TAVR: in the Co-STAR trial treatment with colchicine was associated with a lower risk of cardiac arrhythmias and subclinical leaflet thrombosis at 30 days. #TCT2024

The inflammatory pathway offers a potential therapeutic target in patients undergoing TAVR: in the Co-STAR trial treatment with colchicine was associated with a lower risk of cardiac arrhythmias and subclinical leaflet thrombosis at 30 days. #TCT2024
Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

少し前にCirculationからASとCADに関するreview articleが出ました。 SAVR候補でもTAVI候補でも、「とりあえずCAGして、有意狭窄あれば血行再建追加で」みたいなハートチームにこそ読んでほしい。

Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

・TAVI弁の耐久性 ・劣化したTAV弁がclinical outcomeに与える影響 ・劣化の予測因子 をreal-world registryのデータを用いて解析した論文です。 Discussionで触れましたが、現行のTAVI populationでどこまでecho F/Uを完遂出来ているのか、するべきなのか、を考えさせられる研究でした。

Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

An Editorial on the prespecified subanalysis of the LANDMARK trial. Do "non-inferiority" results in head-to-head comparisons represent that there are no differences between different TAVI platforms? EuroIntervention eurointervention.pcronline.com/article/myval-…

An Editorial on the prespecified subanalysis of the LANDMARK trial.

Do "non-inferiority" results in head-to-head comparisons represent that there are no differences between different TAVI platforms?
<a href="/EuroInterventio/">EuroIntervention</a> eurointervention.pcronline.com/article/myval-…
Daryoush Samim (@daryoushsamim) 's Twitter Profile Photo

ELASTA-Clip followed by transapical TMVR is a less invasive Tx for patients with failed M-TEER, with encouraging early results in carefully selected Pts. Preventing PVL and stroke is crucial. Larger, long-term studies are needed JACC Journals jacc.org/doi/10.1016/j.…

ELASTA-Clip followed by transapical TMVR is a less invasive Tx for patients with failed M-TEER, with encouraging early results in carefully selected Pts. Preventing PVL and stroke is crucial. Larger, long-term studies are needed <a href="/JACCJournals/">JACC Journals</a> jacc.org/doi/10.1016/j.…
Daijiro Tomii (@daijirotomii) 's Twitter Profile Photo

Honored to share the updated #TAVI chapter in the official PCR-EAPCI Textbook! 📖 🎯 For SHD newcomers & veterans alike — a resource to support your clinical and research journey. 📊 50+ visuals covering: 🔹AS pathophys 🔹Landmark trials 🔹TAVI strategy 🔹Lifetime management